|
1.
|
Angus DC, Linde-Zwirble WT, Lidicker J,
Clermont G, Carcillo J and Pinsky MR: Epidemiology of severe sepsis
in the United States: analysis of incidence, outcome, and
associated costs of care. Crit Care Med. 29:1303–1310. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Brun-Buisson C, Doyon F, Carlet J, et al:
Incidence, risk factors, and outcome of severe sepsis study in
intensive care units. A multicenter prospective study in intensive
care units. JAMA. 274:968–974. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Levy MM, Fink MP, Marshall JC, et al: 2001
SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions
Conference. Crit Care Med. 31:1250–1256. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Waterer GW and Wunderink RG: Science
review: genetic variability in the systematic inflammatory
response. Crit Care. 7:308–314. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Sorensen TI, Nielsenm GG, Andersen PK and
Teasdale TW: Genetic and environmental influences on premature
death in adult adoptees. N Engl J Med. 318:727–732. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Eigler A, Sinha B, Hartmann G and Endres
S: Taming TNF: strategies to restrain this proinflammatory
cytokine. Immunology Today. 18:487–492. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Zhang D-L, Li J-S, Jiang Z-W, Yu B-J, Tang
X-M and Zheng H-M: Association of two polymorphism of tumor
necrosis factor gene with acute biliary pancreatitis. World J
Gastroenterol. 9:824–828. 2003.PubMed/NCBI
|
|
8.
|
Holmes CL, Russell JA and Walley KR:
Genetic polymorphisms in sepse and septic shock-role in prognosis
and potencial for therapy. Chest. 124:1103–1115. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Messer G, Spengler U, Jung MC, et al:
Polymorphic structure of the tumor necrosis factor (TNF) locus: an
Nco1 polymorphism in the first intron of the human TNF-beta gene
correlates with a variant amino acid in position 26 and a reduced
level of TNF-beta production. J Exp Med. 173:209–219. 1991.
View Article : Google Scholar
|
|
10.
|
Stuber F, Petersen M, Bokelmann F and
Schade U: A genomic polymorphism within the tumor necrosis factor
locus influences plasma tumor necrosis factor-α concentrations and
outcome of patients with severe sepsis. Crit Care Med. 24:381–384.
1996.
|
|
11.
|
Majetschak M, Flohé S, Obertacke U, et al:
Relation of a TNF gene polymorphism to severe sepsis in trauma
patients. Ann Surg. 203:207–214. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Majetschak M, Obertacke U, Schade FU, et
al: Tumor necrosis factor gene polymorphisms, leukocyte function,
and sepsis susceptibility in blunt trauma patients. Clin Diagn Lab
Immunol. 9:1205–1211. 2002.PubMed/NCBI
|
|
13.
|
Knaus WA, Zimmermann JE, Wagner DP, Draper
EA and Laurence DE: APACHE – acute physiology and chronic health
evaluation: a physiologically based classification system. Crit
Care Med. 9:591–597. 1981.
|
|
14.
|
Ferreira FL, Bota DP, Bross A, Mélt C and
Vincent JL: Serial evaluation of the SOFA score to predict outcome
in critically ill patients. JAMA. 286:1754–1758. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Miller AS, Dykes DD and Polesky HS: A
simple salting out procedure for extraction DNA from human
nucleated cells. Nucleic Acid Res. 16:1215–1219. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Reiche EMV, Bonametti AM, Watanabe MAE, et
al: Socio-demographic and epidemiological characteristics
associated with human immunodeficiency virus type 1 (HIV-1)
infection in HIV-1-exposed but uninfected individuals, and in
HIV-1-infected patients from a southern Brazilian population. Rev
Inst Med Trop Sao Paulo. 47:239–246. 2005. View Article : Google Scholar
|
|
17.
|
Dean AG, Dean JA, Coulombier D, Brendel
KA, Smith DC and Burton H: Epi Info, Version 6: a Word-Processing
Database, and Statistics Program for Public Health on
IBM-Compatible Microcomputers. Centers for Disease Control and
Prevention, Atlanta, GA, USA. 1995.
|
|
18.
|
SAS Institute Inc: SAS/STAT User's Guide,
Version 6. Fourth Edition. SAS Institute Inc; Cary, NC: 1989
|
|
19.
|
Sutherland AM and Russell JA: Issues with
polymorphism analysis in sepsis. Clin Infect Dis. 41:S396–S402.
2005. View
Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Waterer GW, Quasney MW, Cantor RM, et al:
Septic shock and respiratory failure in community-acquired
pneumonia have different TNF polymorphism associations. Am J Respir
Crit Care Med. 163:1599–1604. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Degoricija V, Sharma M, Legac A, Gradiser
M, Sefer S and Vucicevic Z: Survival analysis of 314 episodes of
sepsis in medical intensive care unit in University Hospital:
impact of intensive care unit performance and antimicrobial
therapy. Croat Med J. 47:385–397. 2006.PubMed/NCBI
|
|
22.
|
Brun-Buisson C, Meshaka P and Pinton P;
Vallet B; EPISEPSIS Study Group: EPISEPSIS: a reappraisal of the
epidemiology and outcome of severe sepsis in French intensive care
units. Intensive Care Med. 30:580–588. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Esteban A, Frutos-Vivar F, Ferguson ND, et
al: Sepsis incidence and outcome: contrasting the intensive care
unit with the hospital ward. Crit Care Med. 35:1284–1289. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Mikawa AY, Tagliavini SA and Costa PI:
CCR5 genotype and plasma β-chemokine concentration of Brazilian
HIV-infected individuals. Braz J Med Biol Res. 35:1333–1337.
2002.
|
|
25.
|
Ribeiro MA: Levels of C-reactive protein
in serum samples from healthy children and adults in São Paulo,
Brazil. Braz J Med Biol Res. 30:1055–1059. 1997.PubMed/NCBI
|
|
26.
|
Povoa P, Almeida E, Moreira P, et al:
C-reactive protein as an indicator of sepsis. Intensive Care Med.
24:1052–1056. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Westendorp RGJ, Langermans JAM, Huizinga
TWJ, Verweij CL and Sturk A: Genetic influence on cytokine
production and fatal meningococcal disease. Lancet. 349:170–173.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Van der Linden MW, Huizinga TW, Stoeken
DJ, Sturk A and Westerndorp RG: Determination of tumor necrosis
factor-alpha and interleukin-10 production in a whole blood
stimulation system: assessment of laboratory error and individual
variation. J Immunol Methods. 218:63–71. 1998.
|
|
29.
|
Yan M, Zhao L, Zheng F, Sun X, Zhang Y and
Wang C: The relationship between gene polymorphism and CRP level in
a Chinese Han population. Biochem Genet. 45:1–9. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Danik JS and Ridker PM: Genetic
determinants of C-reactive protein. Curr Atheroscler Rep.
9:195–203. 2007. View Article : Google Scholar
|
|
31.
|
Martinez-Calatrava MJ, González-Sanches
JL, Martinez-Larrad MT, Pérez-Barba M and Serrano-Ríos M: Common
haplotypes of the C-reactive protein gene and circulating leptin
levels influence the interindividual variability in serum
C-reactive protein levels. The Segovia study Thromb Haemost.
98:1088–1095. 2007.
|
|
32.
|
Posch PE, Cruz I, Bradshaw D and Medhekar
BA: Novel polymorphisms and the definition of promoter alleles of
the tumor necrosis factor and lymphotoxin α loci: inclusion in HLA
haplotypes. Genes and Immunity. 4:547–558. 2003.PubMed/NCBI
|
|
33.
|
Tsytsykova AV, Rajsbaum R, Falvo JV,
Ligeiro F, Neely SR and Goldfeld AE: Activation-dependent
intrachromosomal interactions formed by the TNF gene promoter and
two distal enhancers. PNAS. 23:16850–16855. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Kaufmann P, Tilz GP, Lueger A and Demel U:
Elevated plasma levels of soluble tumor necrosis factor receptor
(sTNFp60) reflect severity of acute pancreatitis. Intensive Care
Med. 23:841–848. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Dhainaut JF, Vincent JL, Richard C, et al:
CDP571, a humanized antibody to human tumor necrosis factor-alpha:
safety, pharmacokinetics, immune response, and influence of the
antibody on cytokine concentrations in patients with septic shock.
CPD571 Sepsis Study Group. Crit Care Med. 23:1461–1469. 1995.
View Article : Google Scholar
|
|
36.
|
Aggarval BB and Natarajan K: Tumor
necrosis factors: developments during the last decade. Eur Cytokine
Netw. 7:93–124. 1996.PubMed/NCBI
|
|
37.
|
Keel M, Ercknauer E, Stocker R, et al:
Different pattern of local and systemic release of proinflammatory
and anti-inflammatory mediators in severely injured patients with
chest trauma. J Trauma. 40:907–912. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Andrejko KM and Deutschman CS: Acute-phase
gene expression correlates with intrahepatic tumor necrosis factor
alpha abundance but not with plasma tumor necrosis factor
concentrations during sepsis/systemic inflammatory response
syndrome in the rat. Crit Care Med. 24:1947–1952. 1996. View Article : Google Scholar
|
|
39.
|
Pellegrini JD, Puyana JC, Lapchak PH,
Kodys K and Millergraziano CL: A membrane TNF-alpha/TNFR ratio
correlates to MODS score and mortality. Shock. 6:389–396. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Bagby GJ, Plessala KL, Wilson LA, Thompson
JJ and Nelson S: Divergent efficiency of antibody to tumor necrosis
factor-α intravascular and peritonitis model of sepsis. J Infect
Dis. 163:83–88. 1991.
|
|
41.
|
Wakabayashi G, Gelfand JA, Jung WK,
Connoly RJ, Burke JF and Dinarello CA: Staphylococcus epidermidis
induces complement activation, tumor necrosis factor and
interleukin-1, a shock-like state and tissue injury in rabbits
without endotoxemia: comparison to Escherichia coli. J Clin
Invest. 87:1925–1935. 1991. View Article : Google Scholar
|
|
42.
|
Kurt AN, Aygun AD, Godekmerdn A, Kurt A,
Dogan Y and Yilmaz E: Serum IL-1β, IL-6, IL-8, and TNF-α levels in
early diagnosis and management of neonatal sepsis. Mediators
Inflamm. 31397:2007 View Article : Google Scholar
|
|
43.
|
Bont ES, Martens A, van Raan J, Samson G,
Fetter WP, Okken A and de Leij LH: Tumor necrosis factor-α,
interleukin-β, and interleukin-6 plasma levels in neonatal sepsis.
Pediatr Res. 33:380–383. 1993.
|
|
44.
|
Ozdemir A, Oygur N, Gultekin M, Coskun M
and Yegin O: Neonatal tumor necrosis factor, interleukin-1α,
interleukin-1β, and interleukin-6 response to infection. Am J
Perinatol. 11:282–285. 1994.
|
|
45.
|
Miller LC, Isa S, LoPreste G, Schaller JG
and Dinarello CA: Neonatal interleukin-1β, interleukin-6, and tumor
necrosis factor: cord blood levels and cellular production. J
Pediatr. 117:961–965. 1990.
|
|
46.
|
Edgar JDM, Wilson DC and McMillan SA:
Predictive value of soluble immunological mediators in neonatal
infection. Clin Sci. 87:165–171. 1994.PubMed/NCBI
|
|
47.
|
Santana Reyes C, García-Muñoz F, Reyes D,
González G, Dominguez C and Domenech E: Role of cytokines
(interleukin-1beta, 6, 8, tumour necrosis factor-alpha, and soluble
receptor of interleukin-2) and C-reactive protein in the diagnosis
of neonatal sepsis. Acta Paediatr. 92:221–227. 2003.PubMed/NCBI
|
|
48.
|
Kahlke V, Schafmayer C, Schniewind B,
Seegert D, Schreiber S and Schröder J: Are postoperative
complications genetically determined by TNF-β NcoI gene
polymorphism? Surgery. 135:365–373. 2004.
|
|
49.
|
Garnacho-Montero J, Aldabo-Pallas T,
Garnacho-Montero C, Cayuela A, Jiménez R, Barroso S and Ortiz-Leyba
C: Timing of adequate antibiotic therapy is a greater determinant
of outcome that are TNF and IL-10 polymorphisms in patients with
sepsis. Crit Care. 10:R1112006. View
Article : Google Scholar : PubMed/NCBI
|
|
50.
|
Turner DM, Williams DM, Sankaran D,
Lazarus M, Sinnott PJ and Hutchinson IV: An investigation of
polymorphism in the interleukin-10 gene promoter. Eur J
Immunogenet. 24:1–8. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
51.
|
Fang XM, Schroder S, Hoeft A and Stuber F:
Comparison of two polymorphisms of the interleukin-1 gene family:
interleukin-1 receptor antagonist polymorphism contributes to
susceptibility to severe sepsis. Crit Care Med. 27:1330–1334. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
52.
|
Danis VA, Millington M, Hyland VJ and
Grennan D: Cytokine production by normal human monocytes:
inter-subject variation and relationship to an IL-1 receptor
antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol.
99:303–310. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
53.
|
Fishman D, Faulds G, Jeffery R,
Mohamed-Ali V, Yudkin JS, Humphries S and Woo P: The effect of
novel polymorphism in the interleukin-6 (IL-6) gene on IL-6
transcription and plasma IL-6 levels, and as association with
systemic-onset juveline chronic arthritis. J Clin Invest.
102:1369–1376. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
54.
|
Barber RF, Chang LY, Arnoldo BD, Purdue
GF, Hunt JL, Horton JW and Aragaki CC: Innate immunity SNPs are
associated with risk for severe sepsis after burn injury. Clin Med
Res. 4:250–255. 2006. View Article : Google Scholar : PubMed/NCBI
|
